BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 30796601)

  • 1. [Pharmacological treatment strategies and surgical options for uveitis].
    Garweg JG
    Ophthalmologe; 2019 Oct; 116(10):942-950. PubMed ID: 30796601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comprehensive review and update on the non-biologic treatment of adult noninfectious uveitis: part I.
    Lee K; Bajwa A; Freitas-Neto CA; Metzinger JL; Wentworth BA; Foster CS
    Expert Opin Pharmacother; 2014 Oct; 15(15):2141-54. PubMed ID: 25226529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial.
    Nguyen QD; Merrill PT; Jaffe GJ; Dick AD; Kurup SK; Sheppard J; Schlaen A; Pavesio C; Cimino L; Van Calster J; Camez AA; Kwatra NV; Song AP; Kron M; Tari S; Brézin AP
    Lancet; 2016 Sep; 388(10050):1183-92. PubMed ID: 27542302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uveitis Therapy: The Corticosteroid Options.
    Valdes LM; Sobrin L
    Drugs; 2020 Jun; 80(8):765-773. PubMed ID: 32350761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Uveitis associated with juvenile idiopathic arthritis : Optimization of immunomodulatory therapy].
    Heiligenhaus A; Tappeiner C; Walscheid K; Heinz C
    Ophthalmologe; 2016 May; 113(5):391-7. PubMed ID: 27142035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Road to remission: a comprehensive review of therapy in uveitis.
    Siddique SS; Shah R; Suelves AM; Foster CS
    Expert Opin Investig Drugs; 2011 Nov; 20(11):1497-515. PubMed ID: 21936708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of the Cochrane Review: Cortisteroid Implants for Chronic Non-Infectious Uveitis. Cochrane Database Syst Rev. 2016;2:CD010469].
    Leal I; Sousa DC; Costa J; Vaz-Carneiro A
    Acta Med Port; 2018 May; 31(5):243-246. PubMed ID: 29916354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retisert: is the new advance in treatment of uveitis a good one?
    Mohammad DA; Sweet BV; Elner SG
    Ann Pharmacother; 2007 Mar; 41(3):449-54. PubMed ID: 17341531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal injection of low-dose gentamicin for the treatment of recurrent or persistent uveitis in horses: Preliminary results.
    Fischer BM; McMullen RJ; Reese S; Brehm W
    BMC Vet Res; 2019 Jan; 15(1):29. PubMed ID: 30651102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of systemic therapy for noninfectious uveitis.
    Ormaechea MS; Hassan M; Onghanseng N; Park JH; Mahajan S; Al-Kirwi KY; Uludag G; Halim MS; Schlaen A; Sepah YJ; Do DV; Nguyen QD
    Expert Opin Drug Saf; 2019 Dec; 18(12):1219-1235. PubMed ID: 31801415
    [No Abstract]   [Full Text] [Related]  

  • 11. [Sarcoidosis and uveitis : An update].
    Garweg JG
    Ophthalmologe; 2017 Jun; 114(6):525-533. PubMed ID: 27904945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal Sirolimus for the Treatment of Noninfectious Uveitis: Evolution through Preclinical and Clinical Studies.
    Nguyen QD; Merrill PT; Sepah YJ; Ibrahim MA; Banker A; Leonardi A; Chernock M; Mudumba S; Do DV
    Ophthalmology; 2018 Dec; 125(12):1984-1993. PubMed ID: 30060978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-Infectious Uveitis: Optimising the Therapeutic Response.
    Airody A; Heath G; Lightman S; Gale R
    Drugs; 2016 Jan; 76(1):27-39. PubMed ID: 26645222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of 'sunset glow fundus' in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease.
    Abu El-Asrar AM; Dosari M; Hemachandran S; Gikandi PW; Al-Muammar A
    Acta Ophthalmol; 2017 Feb; 95(1):85-90. PubMed ID: 27535102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluocinolone acetonide sustained drug delivery device to treat severe uveitis.
    Jaffe GJ; Ben-Nun J; Guo H; Dunn JP; Ashton P
    Ophthalmology; 2000 Nov; 107(11):2024-33. PubMed ID: 11054326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of intermediate uveitis].
    Doycheva D; Deuter C; Zierhut M
    Ophthalmologe; 2014 Dec; 111(12):1219-32; quiz 1233-4. PubMed ID: 25448321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current therapeutic approaches to autoimmune chronic uveitis in children.
    Simonini G; Cantarini L; Bresci C; Lorusso M; Galeazzi M; Cimaz R
    Autoimmun Rev; 2010 Aug; 9(10):674-83. PubMed ID: 20553975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of intravitreal anti-tumour necrosis factor drugs in adults with non-infectious uveitis - a systematic review.
    Leal I; Rodrigues FB; Sousa DC; Romão VC; Duarte GS; Carreño E; Dick AD; Marques-Neves C; Costa J; Fonseca JE
    Acta Ophthalmol; 2018 Sep; 96(6):e665-e675. PubMed ID: 29577629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Side-effects of anti-inflammatory therapy in uveitis.
    Uchiyama E; Papaliodis GN; Lobo AM; Sobrin L
    Semin Ophthalmol; 2014; 29(5-6):456-67. PubMed ID: 25325874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNF inhibition for ophthalmic indications: current status and outlook.
    Rifkin LM; Birnbaum AD; Goldstein DA
    BioDrugs; 2013 Aug; 27(4):347-57. PubMed ID: 23568177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.